- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07512713
Abbreviated Title: Airway Opening Pressure in Mechanically VENTilated Patients (AOP-VENT)
Assessment of Airway Opening Pressure in Critically Ill Adults Receiving Mechanical Ventilation: a Multicenter Prospective Observational Cohort Study
Context:
Mechanical ventilation is an essential treatment for patients admitted to intensive care. It is estimated that approximately 50% of adult patients admitted to intensive care require invasive mechanical ventilation. However, inappropriate ventilator settings expose patients to the risk of ventilator-induced lung injury (VILI). In particular, the cyclical opening and closing of the alveolar units can damage lung tissue and trigger an inflammatory response.
Measuring and monitoring airway pressure (Paw), particularly plateau pressure (Pplat) and driving pressure (DP), is essential in order to adjust ventilator settings and is the subject of international recommendations.
However, these static pressures may not accurately reflect alveolar pressure. Partial or complete closure of the airways can influence the measurement of Pplat and DP. Airway closure corresponds to an interruption in communication between the proximal airways and the alveoli when airway pressure is below the airway opening pressure (AOP) threshold (airway opening pressure or AOP). In the event of such closure, insufflation only begins when the airway pressure reaches this critical threshold. Consequently, in the event of airway closure, the airway pressure may differ from the alveolar pressure and thus distort the assessment of respiratory mechanics. Furthermore, when positive end-expiratory pressure (PEEP) is set below the critical AOP threshold, cyclic opening and closure of the alveolar units may occur, potentially contributing to VILI.Detection of airway closure and measurement of the corresponding AOP can be performed at the patient's bedside by simply examining the ventilator curves during slow-flow insufflation or by measuring conductive pressure. Despite the potential implications of airway closure for the assessment of respiratory mechanics in mechanically ventilated patients, its prevalence is not defined. It has been reported that this phenomenon may affect 20 to 50% of patients with acute respiratory distress syndrome (ARDS). It has also been suggested that this phenomenon may affect obese patients, asthmatic patients, or patients receiving insufficient PEEP.
Objectives:
The main objective of this multicentre observational study is to assess the prevalence of airway closure in a large population of adults in intensive care receiving invasive mechanical ventilation.
Type of study:
Multicentre observational cohort study
Number of centres:
39 intensive care units
Study procedure:
Phase 1: Identification and registration of participating centres Phase 2: Implementation of the study and data collection All patients undergoing invasive mechanical ventilation in controlled mode will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard clinical practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.
No changes will be made to the initial ventilator settings. The data will be collected anonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H+12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).
Phase 3: management and analysis of pseudonymised data
Study Overview
Status
Detailed Description
Eligible patients will be included prospectively over a period of two weeks (14 consecutive days); the two-week period will be left to the discretion of each intensive care unit participating in the research (within a total 'window' of two months). Any patient admitted to intensive care requiring invasive mechanical ventilation in controlled mode for the condition for which they were admitted will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.No changes will be made to the initial ventilator settings. The data will be collated pseudonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).
For newly admitted patients (ventilation duration < 24 hours), in participating centres that accept it, data will be collected upon discharge from intensive care or on day 28, whichever comes first, in order to gather the following prognostic information: total duration of mechanical ventilation up to day 28, time to weaning from ventilation, number of days alive without invasive ventilation support on day 28, mortality on day 28.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Lise LACLAUTRE
- Phone Number: +33 473 754 963
- Email: promo_interne_drci@chu-clermontferrand.fr
Study Locations
-
-
-
Clermont-Ferrand, France
- CHU de Clermont-Ferrand
-
Contact:
- Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
-
Principal Investigator:
- pierre COUHAULT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years old
- Patients admitted to a participating ICU
- Patients receiving invasively ventilation for any cause We will only include patients under controlled mechanical ventilation because airway closure is difficult to assess in spontaneously breathing patients.
Non-inclusion Criteria:
- A patient admitted to hospital or transferred to the intensive care unit without a documented time of intubation
- Have a tracheotomy/tracheostomy at the time of inclusion
- Are receiving an assist ventilation mode
- Patient or relative's refusal to participate for data collection
- Pregnant or breast-feeding women
- Legal protection (i.e., patient under a tutelage, or curatorship, or placed under judicial incarceration)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary outcome is the proportion of critically ill receiving mechanically ventilated patients with complete airway closure (AOP higher than PEEP).
Time Frame: Data collection will be done twice (12-hour intervals) on the day of enrollment in the study. For newly admitted patients to participating ICUs, data collection will be done at day 1 and day 2.
|
Complete airway closure and corresponding AOP will be identified on the pressure-time curve of the ventilator using a low-flow inflation (5 L/min, respiratory rate 5/min, tidal volume 6 mL/kg predicted body weight) after a prolonged exhalation to PEEP 5 cmH2O in volume-controlled mode.
|
Data collection will be done twice (12-hour intervals) on the day of enrollment in the study. For newly admitted patients to participating ICUs, data collection will be done at day 1 and day 2.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mechanical power (MP)
Time Frame: At day 1 and day 2 (if inclusion criteria are met)
|
MP will be calculated by the following equation15: MP (J/min) = 0.098 × VT × RR × [PEEP + (0.5 × DP) + (Ppeak - Pplat)], where VT is tidal volume, RR respiratory rate, DP Driving Pressure, Ppeak peak airway pressure and Pplat plateau airway pressure.
|
At day 1 and day 2 (if inclusion criteria are met)
|
|
Mechanical power, computed using AOP instead total PEEP
Time Frame: At day 1 and day 2
|
In patients with airway closure and AOP greater than PEEP
|
At day 1 and day 2
|
|
Conductive pressure (Pcond) and resistive pressure (Pres)
Time Frame: From the ventilator at day 1 and day 2
|
Pcond and Pres will be identified on the pressure-time curve in volume-controlled mode using the initially set flow rate and then using using constant-flow of 50, 60 and 70 L/min. AOP will be calculated by the following equation: AOP = PEEP + (Pcond - Pres) |
From the ventilator at day 1 and day 2
|
|
Driving pressure of the respiratory system (DPrs)
Time Frame: At day 1 and day 2
|
computed as Pplat - PEEP, Driving pressure computed using AOP instead of PEEP (in patients with airway closure and AOP greater than PEEP)
|
At day 1 and day 2
|
|
Total duration to first separation attempt
Time Frame: Upon discharge from intensive care or on day 28
|
Number of days until the first attempt at separation (spontaneous breathing trial or direct extubation)
|
Upon discharge from intensive care or on day 28
|
|
Total duration to successful weaning from the ventilator,
Time Frame: Upon discharge from intensive care or on day 28
|
Defined as extubation followed by 48 hours of spontaneous breathing without mechanical ventilation.
|
Upon discharge from intensive care or on day 28
|
|
Total duration of ventilation
Time Frame: Upon discharge from intensive care or on day 28
|
Total duration of ventilation to ICU discharge or day 28, whichever comes first
|
Upon discharge from intensive care or on day 28
|
|
Days alive and off the ventilator
Time Frame: Upon discharge from intensive care or on day 28
|
Days alive and off the ventilator at ICU discharge or day 28, whichever comes first
|
Upon discharge from intensive care or on day 28
|
|
Reintubation (y/n)
Time Frame: Upon discharge from intensive care or on day 28
|
Reintubation (y/n) at ICU discharge or day 28, whichever comes first
|
Upon discharge from intensive care or on day 28
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse oximetry (SpO2)
Time Frame: At day 1 and day 2
|
Arterial desaturation (SpO2 <90% y/n) during airway closure assessment
|
At day 1 and day 2
|
|
Lowest pulse oximetry (SpO2)
Time Frame: At day 1 and day 2
|
- Lowest pulse oximetry (SpO2) during airway closure assessment
|
At day 1 and day 2
|
Collaborators and Investigators
Investigators
- Principal Investigator: Pierre COUHAULT, PH, CHU de Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RNI 2025 COUHAULT (AOP-VENT)
- ANSM (Other Identifier: 2025-A02220-49)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevalence of Airway Closure
-
Romina Belen MatteiRecruiting
-
Kabul University of Medical SciencesCompletedPrevalence of Cervical Extension of the ThymusAfghanistan
-
Assiut UniversityNot yet recruitingPrevalence of Hemolytic Uremic Syndrome
-
Atlantic Health SystemNot yet recruitingPrevalence of OSA in Patients Hospitalized With COPD Exacerbation
-
National University Hospital, SingaporeCompletedChronic Angle Closure Glaucoma | Primary Angle Closure | Primary Angle Closure Suspect | Fellow Eyes of Acute Angle Closure GlaucomaSingapore
-
Cairo UniversityCompletedThe Prevalence of Bifid Mandibular CanalEgypt
-
Universitaire Ziekenhuizen KU LeuvenCompletedPrevalence of Augmented Renal Clearance | Risk Factors for Augmented Renal ClearanceBelgium
-
InSeal Medical Ltd.CompletedPercutaneous Closure of Artery Access SitesIsrael
-
Manipur International UniversityBrahmakumarisNot yet recruitingDepression | Quality of Life | Prevalence | Anxiety | HappinessNepal
-
University of AarhusTakeda; Aarhus University HospitalCompletedDisruption or Dehiscence of Closure of Sternum or SternotomyDenmark